Receive updates from Patient Advocates and MS specialists sent directly to your inbox.

Sign up now


Lift MS® is designed to educate and motivate patients and Care Partners living with relapsing MS. There are many ways to join this inspiring online community:

You can also make a 1-on-1 connection through Teva’s MS Peer* Program.

Ever wish you could talk to someone who knows what it’s like to live with relapsing MS the way you do? No matter how long it’s been since you were diagnosed, talking to an MS Peer can make all the difference in how you manage your therapy, set expectations and feel about your diagnosis.

To find the right MS Peer match for you, request an MS Peer now by answering a few questions. You’ll be connected with someone whose interests, stage of life and therapy experience are most relevant to yours.

*MS Peers are compensated by Teva.

What is Lift MS®?

The Lift MS® Blog helps raise awareness for the relapsing MS community by empowering people. Through information, motivation and opportunities for action, you’ll discover the lift you’re looking for to live with MS, whether you’re a patient, Care Partner or supportive friend.

Lift MS® Blog

Register now to receive updates from the Lift MS® Blog.

Find the lift you’re looking for, with a community of people who can relate.

If you’re living with relapsing MS, you’re not alone. Join the thousands of people who make up the Lift MS® community on Facebook for ongoing support and inspiration. From tips and tricks to easy, MS-friendly recipes and MS patient stories, there’s no shortage of uplifting moments to encourage you.

Lift MS® Blog

Visit us on Facebook to join the conversation.


COPAXONE® is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not use COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Serious side effects may happen right after or within minutes after you inject COPAXONE® at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.

You can have chest pain as part of an immediate post-injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using COPAXONE®. Call your doctor right away if you have chest pain while using COPAXONE®.

Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use COPAXONE®. Damage to the fatty tissue under your skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by following your doctor’s instructions for how to use COPAXONE® and choosing a different injection area each time you use COPAXONE®.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the injection site; rash; shortness of breath; flushing; and chest pain.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of COPAXONE®. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please read the Patient Information in the full Prescribing Information.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?